Literature DB >> 3286172

Treatment of systemic lupus erythematosus.

M B Burlingame1, J C Delafuente.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with clinical manifestations involving a multitude of tissue sites. This article describes the pathophysiology, etiology, clinical manifestations, and therapy of SLE, and focuses mainly on drugs used in SLE treatment. The reader will be able to identify which pharmacologic agents are used in SLE and list the drugs that are useful for specific clinical manifestations. The reader will also be able to describe the common adverse drug reactions seen from SLE treatment and the potential risks involved with these therapies. Information on expected outcomes from drug therapy that will aid in monitoring patients receiving treatment for SLE is provided.

Entities:  

Mesh:

Year:  1988        PMID: 3286172     DOI: 10.1177/106002808802200401

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  1 in total

1.  Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.

Authors:  P Appleby; D G Webber; J G Bowen
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.